Primus In News
Precision oncology gains ground as India clears targeted cancer therapies
25-12-2025
Nilaya Varma, Group CEO and Co-Founder,Primus Partners, highlights that the approvals represent a major step toward integrating outcome-based precision medicine into routine cancer care, with combination immunotherapies improving treatment outcomes for patient groups that previously had limited options.
Explore Related Insights
- Students see entrepreneurship as a core pathway to careers and growth
- Indian online gaming sector will contribute 68% to the AVGC industry by 2026: EGROW and Primus Partners report
- Can injections be needle-free, painless? This Pune-based firm has the answer
- The 2007 rate cutting cycle too began on Sep 18, three months before the Great Recession
